NasdaqGM:ZLABBiotechs
Assessing Zai Lab (ZLAB) Valuation After Prolonged Share Price Weakness And Reported Intrinsic Discount
What Zai Lab’s Recent Performance Tells You
Zai Lab (ZLAB) has been on many investors’ radars after a challenging year, with the stock showing a 52% decline over the past 12 months and a mixed return profile more recently.
Over the past month the share price shows a 3.5% decline, while the past 3 months reflect a 3.4% gain and year to date performance stands at 6%. These swings contrast with the company’s reported annual revenue of US$460.2 million and a net loss of US$175.5 million.
For...